Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

Michael J. Reardon, Nicolas M. Van Mieghem, Jeffrey J. Popma, Neal S. Kleiman, Lars Søndergaard, Mubashir Mumtaz, David Adams, G. Michael Deeb, Brijeshwar Maini, Hemal Gada, Stanley Chetcuti, Thomas G. Gleason, John Heiser, Rüdiger Lange, William Merhi, Jae K. Oh, Peter Skov Olsen, Nicolò Piazza, Mathew Williams, Stephan Windecker, Steven J. Yakubov, Eberhard Grube, Raj Makkar, Joon S. Lee, John V. Conte, Eric Vang, Hang Nguyen, Yanping Chang, Andrew S. Mugglin, Patrick W. Serruys, A. Pieter Kappetein

New England Journal of Medicine, 2017

Houston Methodist, Erasmus MC, Hadassah Medical Center, Rigshospitalet, Harrisburg Hospital, Mount Sinai Health System, University of Michigan–Ann Arbor, Tenet Healthcare, University of Pittsburgh Medical Center, Corewell Health Blodgett Hospital, Deutsches Herzzentrum München, Mayo Clinic, McGill University Health Centre, NYU Langone Health, University Hospital of Bern, Riverside Methodist Hospital, Helios Hospital Siegburg, Cedars-Sinai Medical Center, Johns Hopkins University, Medtronic (United States), Paradigm Pharmaceuticals (United States)

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

2937

Citations

View on Google Scholar

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

Abstract

Journal Details

Join JournalsHub

Welcome Back